Skip to main content

Protagonist Therapeutics, Inc

PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001377121

In the last 90 days, Protagonist Therapeutics, Inc insiders filed 0 open-market purchases and 2 sales; 346 institutions reported holding it in 13F filings for Q2 2026, worth $9.30B in total; Duquesne Family Office is the only superinvestor holding it.

13F holders, Q4 2024

Institutional positions in Protagonist Therapeutics, Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
241
+4 vs. Q3 2024
Shares held
63.3M
+1.83M (+3.0%) vs. Q3 2024
Total value
$2.44B
−$321.9M (−11.6%) vs. Q3 2024
New holders
45
91 more added
Sold out
41
76 more reduced

3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PTGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 241 institutions
Q1 2021: 127 institutionsQ2 2021: 139 institutionsQ3 2021: 132 institutionsQ4 2021: 149 institutionsQ1 2022: 140 institutionsQ2 2022: 131 institutionsQ3 2022: 133 institutionsQ4 2022: 137 institutionsQ1 2023: 138 institutionsQ2 2023: 167 institutionsQ3 2023: 144 institutionsQ4 2023: 157 institutionsQ1 2024: 185 institutionsQ2 2024: 188 institutionsQ3 2024: 240 institutionsQ4 2024: 241 institutionsQ1 2025: 275 institutionsQ2 2025: 274 institutionsQ3 2025: 275 institutionsQ4 2025: 319 institutionsQ1 2026: 322 institutionsQ2 2026: 346 institutions
Value heldQ4 2024: $2.44B
Q1 2021: $1.15BQ2 2021: $2.16BQ3 2021: $820.8MQ4 2021: $1.68BQ1 2022: $1.19BQ2 2022: $422.1MQ3 2022: $398.9MQ4 2022: $533.3MQ1 2023: $1.22BQ2 2023: $1.57BQ3 2023: $945.9MQ4 2023: $1.32BQ1 2024: $1.73BQ2 2024: $2.05BQ3 2024: $2.78BQ4 2024: $2.44BQ1 2025: $3.15BQ2 2025: $3.92BQ3 2025: $4.70BQ4 2025: $6.18BQ1 2026: $8.31BQ2 2026: $9.30B
Institutions holding PTGX and their total value by quarter
QuarterHoldersValue
Q2 2026346$9.30B
Q1 2026322$8.31B
Q4 2025319$6.18B
Q3 2025275$4.70B
Q2 2025274$3.92B
Q1 2025275$3.15B
Q4 2024241$2.44B
Q3 2024240$2.78B
Q2 2024188$2.05B
Q1 2024185$1.73B
Q4 2023157$1.32B
Q3 2023144$945.9M
Q2 2023167$1.57B
Q1 2023138$1.22B
Q4 2022137$533.3M
Q3 2022133$398.9M
Q2 2022131$422.1M
Q1 2022140$1.19B
Q4 2021149$1.68B
Q3 2021132$820.8M
Q2 2021139$2.16B
Q1 2021127$1.15B

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Protagonist Therapeutics, Inc; share changes are against Q3 2024.

Institutions holding PTGX in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Asset Management Americas Inc287,911$11.1M0.00%−80,221−21.8%Reduced
Artia Global Partners LP293,851$11.3M4.57%+169,411+136.1%Added
Pictet Asset Management Holding SA296,511$11.4M0.01%+289,213+3,962.9%Added
Raymond James Financial Inc303,313$11.7M0.00%+303,313New
Skandinaviska Enskilda Banken AB (publ)310,650$12.0M0.05%+80,536+35.0%Added
Qube Research & Technologies Ltd312,319$12.1M0.02%−10,670−3.3%Reduced
Kennedy Capital Management, Inc.321,526$12.4M0.28%+54,493+20.4%Added
Principal Financial Group Inc337,809$13.0M0.01%+16,977+5.3%Added
Driehaus Capital Management LLC339,698$13.1M0.11%−105,654−23.7%Reduced
Toronto Dominion Bank340,974$13.2M0.03%+340,974New
Polar Capital Holdings Plc350,000$13.5M0.08%00.0%Unchanged
Bank of New York Mellon Corp390,788$15.1M0.00%+34,455+9.7%Added
Kynam Capital Management, LP390,792$15.1M1.00%−65,577−14.4%Reduced
Mangrove Partners395,383$15.3M1.82%−43,931−10.0%Reduced
683 Capital Management, LLC410,000$15.8M1.56%−10,000−2.4%Reduced
Colony Group, LLC425,557$16.4M0.04%−1,104−0.3%Reduced
FMR LLC442,516$17.1M0.00%−11,680−2.6%Reduced
Morgan Stanley540,315$20.9M0.00%−88,308−14.0%Reduced
JPMorgan Chase & Co576,977$22.3M0.00%+73,992+14.7%Added
Charles Schwab Investment Management Inc578,409$22.3M0.00%+12,906+2.3%Added
Woodline Partners LP582,327$22.5M0.15%+115,809+24.8%Added
Northern Trust Corp628,580$24.3M0.00%+48,491+8.4%Added
Eversept Partners, LP678,787$26.2M2.70%+233,583+52.5%Added
Invesco Ltd.738,952$28.5M0.01%+85,800+13.1%Added
Goldman Sachs Group Inc758,690$29.3M0.01%−63,166−7.7%Reduced
American Century Companies Inc928,286$35.8M0.02%+353,511+61.5%Added
Wellington Management Group LLP940,077$36.3M0.01%+909,998+3,025.4%Added
Deep Track Capital, LP1,000,000$38.6M1.45%+1,000,000New
ADAR1 Capital Management, LLC1,020,333$39.4M8.12%+39,038+4.0%Added
Perceptive Advisors LLC1,271,662$49.1M1.37%−102,901−7.5%Reduced
Geode Capital Management, LLC1,377,063$53.2M0.00%+2,366+0.2%Added
Price T Rowe Associates Inc1,392,652$53.8M0.01%+83,185+6.4%Added
Jefferies Financial Group Inc.1,489,495$57.5M0.64%−325,201−17.9%Reduced
Pacer Advisors, Inc.1,876,466$72.4M0.16%+142,376+8.2%Added
BVF Inc1,900,015$73.3M2.49%+49,848+2.7%Added
Johnson & Johnson2,449,183$94.5M24.48%00.0%Unchanged
State Street Corp3,331,061$128.6M0.01%+147,519+4.6%Added
Vanguard Group Inc4,220,037$162.9M0.00%+3,956+0.1%Added
RTW Investments, LP5,498,545$212.2M3.21%+72,433+1.3%Added
Farallon Capital Management, L.L.C.5,930,006$228.9M1.21%+69,000+1.2%Added
BlackRock, Inc.9,884,617$381.5M0.01%−339,678−3.3%Reduced
Adage Capital Partners GP, L.L.C.0$00.00%−1,200,891−100.0%Sold out
Cowen and Company, LLC0$00.00%−340,974−100.0%Sold out
Checkpoint Capital L.P.0$00.00%−240,000−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−214,872−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−162,492−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−146,657−100.0%Sold out
Segall Bryant & Hamill, LLC0$00.00%−120,301−100.0%Sold out
Walleye Capital LLC0$00.00%−105,335−100.0%Sold out
Weiss Asset Management LP0$00.00%−62,463−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−61,026−100.0%Sold out
Point72 Europe (London) LLP0$00.00%−45,317−100.0%Sold out
Jackson Creek Investment Advisors LLC0$00.00%−44,685−100.0%Sold out
SG Americas Securities, LLC0$00.00%−25,740−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−25,095−100.0%Sold out
Financial Enhancement Group LLC0$00.00%−41,818−100.0%Sold out
Janney Montgomery Scott LLC0$00.00%−19,249−100.0%Sold out
Squarepoint Ops LLC0$00.00%−18,566−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−13,993−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−13,858−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−12,100−100.0%Sold out
HighTower Advisors, LLC0$00.00%−10,887−100.0%Sold out
MYDA Advisors LLC0$00.00%−10,000−100.0%Sold out
Teza Capital Management LLC0$00.00%−9,463−100.0%Sold out
Nomura Holdings Inc0$00.00%−8,159−100.0%Sold out
Everence Capital Management Inc0$00.00%−7,050−100.0%Sold out
Entropy Technologies, LP0$00.00%−6,929−100.0%Sold out
Brinker Capital Investments, LLC0$00.00%−6,114−100.0%Sold out
Orion Portfolio Solutions, LLC0$00.00%−6,114−100.0%Sold out
CenterBook Partners LP0$00.00%−5,976−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−5,251−100.0%Sold out
Palumbo Wealth Management LLC0$00.00%−5,211−100.0%Sold out
AXA S.A.0$00.00%−4,888−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−4,551−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−2,699−100.0%Sold out
Lazard Asset Management LLC0$00.00%−2,697−100.0%Sold out
Globeflex Capital L P0$00.00%−2,627−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−140−100.0%Sold out
True Wealth Design, LLC0$00.00%−96−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−79−100.0%Sold out
Signaturefd, LLC0$00.00%−20−100.0%Sold out
Mendota Financial Group, LLC0$00.00%−6−100.0%Sold out
Eagle Asset Management Inc––––Not filed
Raymond James & Associates––––Not filed
PEAK6 Investments LLC––––Not filed